Pashtoon Kasi, Medical Director of GI Medical Oncology at City of Hope Orange County, shared a post on LinkedIn:
“New in Science Advances.
This is what functional precision oncology looks like.
From the clinic, we helped support a pan-cancer ORGANOID platform — 220 PDOs, 191 patients, 15 cancer types.
Finding options biomarker testing will miss.”
Title: Patient-derived organoids across cancers reveal conserved tumor heterogeneity and actionable therapeutic vulnerabilities
Authors: Hui-Hsuan Kuo, Bhavneet Bhinder, Hamza N. Gokozan, Kathryn Gorski, Pooja Chandra, Jyothi Manohar, Daniela Guevara, John Otilano, Jenna Moyer, Marvel Tranquille, Sarah Ackermann, Jared Capuano, Cynthia Cheung, Thomas A. Caiazza, Phoebe L. Reuben, Anastasia Murray Tsomides, Adriana Irizarry, Michael Sigouros, David Wilkes, Abigail King, Troy Kane, Majd Al Assaad, Wael Al Zoughbi, Kentaro Ohara, Joonghoon Auh, Peter Waltman, Florencia P. Madorsky Rowdo, Enrique Podaza, Valerie Gallegos, John Nguyen, Raehash Shah, Manish Shah, Allyson Ocean, Douglas Scherr, Nasser Altorki, Melissa Frey, Ana M. Molina, Lisa Newman, Vivan Bea, Eloise Chapman-Davis, Marcus D. Goncalves, Ashish Saxena, Parul J. Shukla, Kevin Holcomb, Rachel Simmons, Scott Tagawa, Jonathan H. Zippin, Evelyn Cantillo, Rohit Chandwani, Melissa Davis, Kelly Garrett, Pashtoon M. Kasi, Jennifer Marti, David Nanus, Jones T. Nauseef, Elizabeth Popa, Momin T. Siddiqui, Alicia Alonso, Cora N. Sternberg, Bishoy M. Faltas, Olivier Elemento, Juan Miguel Mosquera, Andrea Sboner, M. Laura Martin
Other articles featuring Pashtoon Kasi on OncoDaily.
